Europe Enteral Nutrition Market

The Europe enteral nutrition market size is projected to reach US$ 5,797.18 million by 2031 from US$ 3,322.95 million in 2023. The market is expected to register a CAGR of 7.2% during 2023–2031. Standardized formulations and plant-based nutrition products are likely to bring in new market trends during the forecast period.

Standardized Formulations and Plant-Based Nutrition Products

There is a surge in the demand for products that help consumers proactively manage their health, especially those focused on specific needs in terms of energy levels, immunity, and disease treatment. Functionality and specific formulations of enteral products do not interfere with the existing treatments of patients. The macro-nutrient and micronutrient formulations of enteral nutrition and their applications vary based on the disease under consideration. Isocaloric enteral nutrition formulation (1 kcal/ml) is generally prescribed to achieve estimated or measured caloric goals, while energy-dense formulae (>1 kcal/ml) are prescribed to increase calorie delivery in patients with gastrointestinal dysfunction.

Standardized enteral nutrition products contain fixed constituents and are designed to meet the average nutritional requirements of patients, considering that the requirements differ in different age groups. For example, Peptamen Formula (Nestle) is the only peptide-based formula with enzymatically hydrolyzed 100% whey protein that helps overcome tube-feeding intolerance. Such tube-feeding formulas are specialized enteral nutrition products designed to support absorption and overcome tolerance mechanisms in individuals with gastrointestinal disorders.

A surge in the number of people turning to plant-based food triggers the demand for plant-based nutrition products worldwide. People are becoming increasingly intolerant of artificial/synthetically sourced ingredients used in higher numbers, which may lead to adverse reactions. The Innova Consumer Survey 2020 showed that health, diet variety, sustainability, and taste are among the top reasons why people consider plant-based alternatives. Abbott states that consumers and patients relying on tube feeding also pay much attention to these parameters. Companies in the Europe enteral nutrition market are capitalizing on the growing preference for healthy foods in various demographic groups. As a result, companies such as Kate Farms, Functional Formularies, and Real Food Blends have developed more natural, plant-based enteral products. In August 2021, Kate Farms launched the first closed feeding system delivering plant-based formulas in ready-to-hang bags of 1 L capacity. Kate Farms Standard 1.4 plain and Peptide 1.5 plain formulations are plant-based, organic, calorically dense products that are used as a sole source of supplemental nutrition in tube feeding. In September 2021, Abbott introduced a portfolio of plant-based proteins and organic food ingredients for children and adults.

Therefore, functional, patient-centric formulations and plant-based nutrition products are the prime emerging trends in the Europe enteral nutrition market.

France Enteral Nutrition Market Analysis  

According to a Le Monde article published in March 2023, the population share of people aged 60 or more in France is expected to surge from ~20% in 2023 to ~30% by 2050. The number of people aged 85 and above would grow by nearly 90% during 2030–2050. Older adults often experience chronic conditions such as diabetes, cardiovascular diseases, and neurological disorders (e.g., stroke, Parkinson's disease, and Alzheimer's). These conditions can impair the ability to eat normally, leading to malnutrition and requiring enteral feeding. According to the Global Cancer Observatory, France reported 483,568 new cancer cases in 2022, and the number of prevalent cases (5-year) was 1,494,814. Cancer and enteral nutrition are closely connected. Many cancer patients suffer from malnutrition due to the disease itself or the treatments they receive, which can impair their ability to eat and absorb essential nutrients.

Fresenius Kabir France offers a diverse portfolio of ready-to-use enteral nutrition products such as tube feeds, oral nutritional supplements (ONS), and powder products. For patients with dysphagia, the company offers texture-modified products in different consistencies to meet the individual needs of different patients.  

Europe Enteral Nutrition Market Report Segmentation Analysis

Key segments that contributed to the derivation of the Europe enteral nutrition market analysis are type, material, and end user.

• Based on product type, the Europe enteral nutrition market is segmented into Nasogastric, Nasoenteral, Sipping and Others. The nasogastric segment held the largest share of the market in 2023.  

A few prominent players operating in the Europe enteral nutrition market are Nestlé, Danone S.A., Abbott Laboratories, Friesland Campina, Fresenius SE and Co. KGaA, B. Braun SE, Dr. Schär AG, Arla Food, Reckitt Benckiser, Perrigo Company PLC, Fonterra Co-operative Group Limited, Kate Farms, and Nutritional Medicinals, LLC among others.

Companies are launching new and innovative products and services to sustain their position in the Europe  enteral nutrition market size. In November 2021, Abbott Launched Similac 360 Total Care to Support the Immune System, Digestive Health, and Brain Development. Similac 360 Total Care is the first and only infant formula in the U.S. with a blend of five different HMOs, previously only found together in breast milk. This formula is designed to provide nutrition to support the whole baby’s health and development, including the developing immune system, digestive system, and brain. 

Europe Enteral Nutrition Strategic Insights

Strategic insights for the Europe Enteral Nutrition provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Europe Enteral Nutrition Report Scope

Europe Enteral Nutrition Regional Insights

The geographic scope of the Europe Enteral Nutrition refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.